Hartley, Benjamin F.
Barnes, Neil C.
Lettis, Sally http://orcid.org/0000-0002-2238-8144
Compton, Chris H.
Papi, Alberto
Jones, Paul
Funding for this research was provided by:
GlaxoSmithKline plc (207941)
Article History
Received: 13 August 2019
Accepted: 13 December 2019
First Online: 6 January 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The authors declare the following real or perceived conflicts of interest during the last 3 years in relation to this work. NCB, CHC, SL, PJ are employees of and hold stock in GlaxoSmithKline. BFH is contracted to work on behalf of GlaxoSmithKline plc through a clinical research organization and holds stock in GlaxoSmithKline. AP reports grants, personal fees, and/or reimbursement of travel expenses from AstraZeneca, Chiesi, Boehringer Ingelheim, GlaxoSmithKline, Menarini, Merck Sharp & Dohme, Mundipharma, Novartis, Teva, Sanofi, and Zambon.